Hope for vascular cognitive impairment: Ac-YVAD-cmk as a novel treatment against white matter rarefaction
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0299703 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yun-An Lim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. Hauptthemen laut MEDLINE: White Matter, Cognitive Dysfunction, Amino Acid Chloromethyl Ketones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education - Singapore, Agency for Science, Technology and Research.
Abstract (Originalsprache)
Vascular cognitive impairment (VCI) is the second leading cause of dementia with limited treatment options, characterised by cerebral hypoperfusion-induced white matter rarefaction (WMR). Subcortical VCI is the most common form of VCI, but the underlying reasons for region susceptibility remain elusive. Recent studies employing the bilateral cortical artery stenosis (BCAS) method demonstrate that various inflammasomes regulate white matter injury and blood-brain barrier dysfunction but whether caspase-1 inhibition will be beneficial remains unclear. To address this, we performed BCAS on C57/BL6 mice to study the effects of Ac-YVAD-cmk, a caspase-1 inhibitor, on the subcortical and cortical regions. Cerebral blood flow (CBF), WMR, neuroinflammation and the expression of tight junction-related proteins associated with blood-brain barrier integrity were assessed 15 days post BCAS. We observed that Ac-YVAD-cmk restored CBF, attenuated BCAS-induced WMR and restored subcortical myelin expression. Within the subcortical region, BCAS activated the NLRP3/caspase-1/interleukin-1beta axis only within the subcortical region, which was attenuated by Ac-YVAD-cmk. Although we observed that BCAS induced significant increases in VCAM-1 expression in both brain regions that were attenuated with Ac-YVAD-cmk, only ZO-1 and occludin were observed to be significantly altered in the subcortical region. Here we show that caspase-1 may contribute to subcortical regional susceptibility in a mouse model of VCI. In addition, our results support further investigations into the potential of Ac-YVAD-cmk as a novel treatment strategy against subcortical VCI and other conditions exhibiting cerebral hypoperfusion-induced WMR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Physiology, National University of Singapore, Singapore, Singapore.
- Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
- Department of Neurology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Japan Society for the Promotion of Science, Chiyoda-ku, Tokyo, Japan.
- School of Life Sciences, La Trobe University, Bundoora, Victoria, Australia.
ORCID-Profile: Wei Thye Lee, Wei Liang Sim, Satoshi Saito, Thiruma Valavan Arumugam, Gavin Stewart Dawe
Förderung
- Ministry of Education - Singapore
- Agency for Science, Technology and Research
Zitieren
APA
Lim, Y. A., Tan, L. S., Lee, W. T., Sim, W. L., Lv, Y., Takakuni, M., Saito, S., Ihara, M., Arumugam, T. V., Chen, C., Wong, F. W., & Dawe, G. S. (2024). Hope for vascular cognitive impairment: Ac-YVAD-cmk as a novel treatment against white matter rarefaction. PLOS ONE. https://doi.org/10.1371/journal.pone.0299703
Vancouver
Lim YA, Tan LS, Lee WT, Sim WL, Lv Y, Takakuni M, et al. Hope for vascular cognitive impairment: Ac-YVAD-cmk as a novel treatment against white matter rarefaction. PLOS ONE. 2024. doi:10.1371/journal.pone.0299703
BibTeX
@article{Lim2024,
author = {Lim, Yun-An and Tan, Li Si and Lee, Wei Thye and Sim, Wei Liang and Lv, Yang and Takakuni, Maki and Saito, Satoshi and Ihara, Masafumi and Arumugam, Thiruma Valavan and Chen, Christopher and Wong, Fred Wai-Shiu and Dawe, Gavin Stewart},
title = {Hope for vascular cognitive impairment: Ac-YVAD-cmk as a novel treatment against white matter rarefaction},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0299703}
}
EUVIMED